HERCULES, CA--(Marketwired - Aug 3, 2015) - Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIO.B), today announced the launch of the IH-500, a fully automated random access system for blood typing and ...

HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that it has received 510 ...

HERCULES, CA--(Marketwired - Oct 24, 2016) - Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a global provider of life science research and clinical diagnostic products, today announced that ...

Bio-Rad has a diverse portfolio of platforms, reagents, data management and connectivity solutions to cater to different blood typing needs. Using Bio-Rad’s IH- Com patient data management software ...

HERCULES, CA--(Marketwired - May 24, 2017) - Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIOb), a global provider of life science research and clinical diagnostic products, today announced that it ...

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that it has received ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) and the South African National Blood Service (SANBS) have announced that they have substantially completed the rollout of Bio-Rad’s IH-500 ...

Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostic products, today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) ...